JOURNAL BROWSE
Search
Advanced SearchSearch Tips
The spiritual sense, prayer and traditional American Indian healing
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : TANG [HUMANITAS MEDICINE]
  • Volume 2, Issue 1,  2012, pp.1.1-1.6
  • Publisher : Association of Humanitas Medicine
  • DOI : 10.5667/tang.2011.0012
 Title & Authors
The spiritual sense, prayer and traditional American Indian healing
Adams, James David Jr.; Garcia, Cecilia;
  PDF(new window)
 Abstract
A spiritual sense may be present in the human brain. Demonstration of the spiritual sense depends on measuring the behavioral effects of spiritual experiences. These experiences can be induced by prayer, specific chemicals and other stimuli that are known to interact with pyramidal neurons of layer 5 in the cerebral cortex. This work examines the hypothesis that pyramidal neurons are the seat of the spiritual sense. Healers use the spiritual sense to comfort and heal their patients, especially with prayer. Many doctors do not encourage prayer and could learn from healers to use the spiritual sense. Patients should be educated to use prayer in order to get the comfort they need for healing.
 Keywords
spiritual sense;pyramidal neurons;healing;
 Language
English
 Cited by
1.
What can traditional healing do for modern medicine,;

탕, 2014. vol.4. 2, pp.9.1-9.6 crossref(new window)
 References
1.
Adams JD, Garcia C. Palliative care among Chumash people. Evid Based Complement Alternat Med. 2005;2(2):143-147. crossref(new window)

2.
Adams JD Jr, Garcia C. Spirit, mind and body in Chumash healing. Evid Based Complement Alternat Med. 2005;2(4):459-463. crossref(new window)

3.
Alkondon M, Albuquerque EX. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res. 2004;145:109-120. crossref(new window)

4.
al-Krenawi A, Graham JR, Maoz B. The healing significance of the Negev's Bedouin Dervish. Soc Sci Med. 1996;43(1):13-21. crossref(new window)

5.
Appel JB, Callahan PM. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline. Eur J Pharmacol. 1989;159(1):41-46. crossref(new window)

6.
Astin JA, Harkness E, Ernst E. The efficacy of "distant healing": a systematic review of randomized trials. Ann Intern Med. 2000;132(11):903-910. crossref(new window)

7.
Buhner SH. Sacred Plant Medicine Explorations in the Practice of Indigenous Herbalism. (USA: Raven Press), 1996.

8.
Kotler A. In engaged Buddhist reader ten years of engaged Buddhist publishing. (CA: Parallax Press), pp. 3-6, 1996.

9.
Dringenberg HC, Sparling JS, Frazer J, Murdoch J. Generalized cortex activation by the auditory midbrain: mediation by acetylcholine and subcortical relays. Exp Brain Res. 2006;174(1):114-123. crossref(new window)

10.
Dringenberg HC, Yahia N, Cirasuolo J, McKee D, Kuo MC. Neocortical activation by electrical and chemical stimulation of the rat inferior colliculus: intra-collicular mapping and neuropharmacological characterization. Exp Brain Res. 2004;154(4):461-469. crossref(new window)

11.
Faber ES, Sah P. Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current. J Neurosci. 2004;24(12):3031-3039. crossref(new window)

12.
El-Seedi HR, De Smet PA, Beck O, Possnert G, Bruhn JG. Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. J Ethnopharmacol. 2005;101(1-3):238-242. crossref(new window)

13.
Faber ES, Sah P. Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current. J Neurosci. 2004;24(12):3031-3039. crossref(new window)

14.
Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187(3):268-283. crossref(new window)

15.
Hofmann A. Teonanacatl and Ololiuqui: Two ancient magic drugs of Mexico. Bull Narcotics. 1971;23:3-14.

16.
Kavasch EB, Baar K. American Indian Healing Arts Herbs, Rituals, and Remedies for Every Season of Life. (USA: Bantam), 1999.

17.
Li Y, Husbands SM, Mahon MF, Traynor JR, Rowan MG. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa opioid receptor. Chem Biodivers. 2007;4(7):1586-1593. crossref(new window)

18.
Marek GJ, Aghajanian GK. 5-Hydroxytryptamine induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by u-opiate receptor activation. Neuroscience. 1998;86(2):485-497. crossref(new window)

19.
McNamara P, Durso R, Brown A, Harris E. The chemistry of religiosity: evidence from patients with Parkinson's disease. In: Where God and Science Meet. How Brain and Evolutionary Studies Alter our Understanding of Religion. McNamara P ed. (Westport: Praeger Publishers), pp. 1-14, 2006.

20.
Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives. J Med Chem. 1997;40(19):2997-3008. crossref(new window)

21.
Newberg A, Waldman MR. How God changes your brain breakthrough findings from a leading neuroscientist. (USA: Ballantine Books), 2010.

22.
Nichols DE, Chemel BR. The neuropharmacology of religious experience: hallucinogens and the experience of the divine. In Where God and Science Meet How Brain and Evolutionary Studies Alter our Understanding of Religion. Volume 3. The Psychology of Religious Experience, McNamara P ed. (Westport: Praeger Publishers), pp. 1-33, 2006.

23.
Nichols DE. Hallucinogens. Pharmacol Ther. 2004;101(2):131-181. crossref(new window)

24.
Nolte KB, Zumwalt RE. Fatal peyote ingestion associated with Mallory-Weiss lacerations. Wester J Med. 1999;170(6):328.

25.
Oken BS. Placebo effects: clinical aspects and neurobiology. Brain. 2008;131(Pt 11):2812-2823. crossref(new window)

26.
Piek T. Neurotoxins from venoms of the Hymenoptera-twenty five years of research in Amsterdam. Comp Biochem Physiol C. 1990;96(2):223-233. crossref(new window)

27.
Polsky A, Mel BW, Schiller J. Computational subunits in thin dendrites of pyramidal cells. Nat Neurosci. 2004;7(6):621-627. crossref(new window)

28.
Radosevich PM, Nash JA, Lacy DB, O'Donovan C, Williams PE, Abumrad NN. Effects of low and high intensity exercise on plasma and cerebrospinal fluid levels of ir-beta-endorphin, ACTH, cortisol, norepinephrine and glucose in the conscious dog. Brain Res. 1989;498(1):89-98. crossref(new window)

29.
Riba J, Rodríguez-Fornells A, Barbanoj MJ. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Psychopharmacology. 2002;165(1):18-28. crossref(new window)

30.
Roberts TB. Chemical input, religious output - entheogens: apharmatheology sampler. In Where God and Science Meet How Brain and Evolutionary Studies Alter our Understanding of Religion. Volume 3. The Psychology of Religious Experience, McNamara P ed. (Westport: Praeger Publishers), pp. 235-67, 2006.

31.
Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ, Mankad S, Rogers WJ, Bairey Merz CN, Sopko G, Cornell E, Sharaf B, Matthews KA. Social networks are associated with lower mortality rates among women with suspected coronary artery disease: the National Heart, Lung and Blood Institute sponsored women's ischemia syndrome evaluation study. Psychosom Med. 2004;66(6):882-888. crossref(new window)

32.
Salak K. The Amazon's Shaman therapy. Nat Geo Adventure. March 2006;1-4.

33.
Seeman P, Guan HC, Hirbec H. Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse. 2009;63(8):698-704. crossref(new window)

34.
Shulgin A, Shulgin A. Pihkal a Chemical Love Story. (CA: Transform Press), 1991.

35.
Sjostrom PJ, Häusser M. A cooperative switch determines the sign of synaptic plasticity in distal dendrites of neocortical pyramidal neurons. Neuron. 2006;51(2):227-238. crossref(new window)

36.
Smith DE, Cromy R, Downing J, Sutton L. Symposium: Psychedelic drugs and religion. J Psychedelic Drugs. 1967;1(2):1-19. crossref(new window)

37.
Tayebati SK, Di Tullio MA, Amenta F. Muscarinic cholinergic receptor subtypes in cerebral cortex of Fisher 344 rats: a light microscopic autoradiography study of age related changes. Mech Ageing Deve. 2006;127(2):115-122. crossref(new window)

38.
Vollenweider FX, Vontobel P, Hell D, Leenders KL. 5-HT modulation of dopamine release in basal ganglia in psilocybin induced psychosis in man a PET study with [11C]raclopride. Neuropsychopharmacology. 1999;20(5):424-433. crossref(new window)

39.
Walsh SL, Strain EC, Abreu ME, Bigelow GE. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology. 2001;157(2):151-162. crossref(new window)

40.
Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger DM, Surmeier DJ. Dopaminergic control of corticostriatal long term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron. 2006;50(3):443-452. crossref(new window)

41.
Wasson RG. The Wondrous Mushroom: Mycolatry in Mesoamerica. (USA: McGraw-Hill), 1980.

42.
Zhang Y, Hamilton SE, Nathanson NM, Yan J. Decreased input specific plasticity of the auditory cortex in mice lacking M1 muscarinic acetylcholine receptors. Cerebral Cortex. 2006;16(9):1258-1265. crossref(new window)